| Chr | chr5 |
| start | 140537340 |
| end | 140558252 |
| lncRNA name | SRA1 |
| entrez id | NA |
| hgnc id | NA |
| ensg id | ENSG00000213523 |
| refseq id | NA |
| methods | qPCR etc. |
| regulated | differential expression |
| function description | Subgroup analysis showed that SRA expression was similar in ER+/PR+ (median = 65.5, n = 8) and in ER-/PR- (median = 94.6, n = 5) tumors. Interestingly, SRA expression in these two subgroups was significantly lower than that observed in ER+/PR- (median = 156.4, n = 6) and ER-/PR+ (median = 144.8, n = 8) tumors. A variant form of SRA, presenting a deletion of 203 bp within the SRA core sequence, was also observed in breast tumor tissues. The relative expression of this new SRA isoform correlated with tumor grade. |
| pubmed id | 10485452 |
| year | 1999 |
| title | Expression of the steroid receptor RNA activator in human breast tumors. |
| drug | X |
| circulating | X |
| survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China